#Neuro Diseases in Africa
Explore tagged Tumblr posts
indianhealthguru · 2 months ago
Text
youtube
Globally, 3.4 billion people, or 43% of the population, live with neurological diseases. In Africa, the impact is particularly severe. Half of all emergency room visits in Africa are linked to neurological complications, with conditions like epilepsy being two to three times more common than in Europe.
0 notes
lisaoshiola · 2 months ago
Text
youtube
In Africa, the impact is particularly severe. Half of all emergency room visits in Africa are linked to neurological complications,
0 notes
communicationblogs · 3 months ago
Text
Neurorehabilitation Devices Market — Forecast(2024–2030)
Neurorehabilitation Devices Market Overview
Tumblr media
Projected to reach USD 5.63 billion by 2030, growing at a CAGR of 14.32% from 2024 to 2030.Neurorehabilitation is a complex medical process that aims to aid the recovery from a nervous system injury and minimize the functional alterations resulting from it. Neurorehabilitation Devices are designed to help and treat patients with the nervous system or neurological diseases. The use of neurorehabilitation devices enhances the intensity and quality of the neurorehabilitation process and ensures optimal rehabilitation of patients with neurological disorders. Technological advancements in transcranial magnetic stimulation and brain computer interface, increasing demand for the appropriate and efficient neuro-rehab devices for Cerebral palsy, growing demand for neuro-robotic devices to provide different ways of treatment depending on the specific function to be restored, increase in the demand for prosthetics devices in the treatment of various diseases and rise in the number of patients suffering from movement disabilities are all the factors that are set to drive the growth of the global Neurorehabilitation Devices Market for the period 2024–2030.
Request Sample
Neurorehabilitation Devices Market Report Coverage
The report: “Neurorehabilitation Devices Market Forecast (2024–2030)”, by Industry ARC covers an in-depth analysis of the following segments of the Neurorehabilitation Devices Market.
By Product Type: Neurorobotics, Brain Computer Interface, Wearable Devices, and Non-invasive Stimulators. By Disease: Stroke, Multiple Sclerosis, Cerebral Palsy, Parkinson’s Disease, and Others. By Geography- North America (U.S., Canada, Mexico), Europe (Germany, United Kingdom (U.K.), France, Italy, Spain, Russia, and the Rest of Europe), Asia Pacific (China, Japan India, South Korea, Australia, and New Zealand, and Rest of Asia Pacific), South America (Brazil, Argentina, Chile, Colombia, and Rest of South America), and Rest of the World (the Middle East, and Africa).
Inquiry Before Buying
Key Takeaways
Geographically, North America Neurorehabilitation Devices Market accounted for the highest revenue share in 2021 and it is poised to dominate over the period 2024–2030 owing to the technological advancements in electrostimulation for the treatment of spinal cord injuries and an increase in the demand for prosthetics devices.
The recent developments in the form of exoskeletons to provide body support to physically disabled and traumatized patients are driving the growth of the neurorobotics segment. However, the Lack of effective training modalities for the robotic devices is one of the major factors that is said to reduce the growth of the Neurorehabilitation Devices Market.
A detailed analysis of strengths, weaknesses, opportunities, and threats will be provided in the Neurorehabilitation Devices Market Report.
Schedule a Call
Neurorehabilitation Devices Market Segmentation Analysis- By Product Type :
The Neurorehabilitation Devices Market-based on the Product Type can be further segmented into Neurorobotics, Brain Computer Interface, Wearable Devices, and Non-invasive Stimulators. The Neurorobotics segment held the largest share in 2021 owing to the growing investments by the manufacturers to develop novel systems and platforms. Neurorobotics have the potential for accurate assessment of motor function to assess the patient status, measure the therapy progress, and give the patient and therapist real-time feedback on movement performance. The recent developments in neurorobotics in the form of exoskeletons to provide body support to the physically disabled and traumatized patients are driving the growth of the Neurorehabilitation Devices Market.
Brain Computer Interface is estimated to be the fastest-growing segment with a CAGR of 16.7% over the period 2024–2030. This is owing to the rise in technological developments facilitating communication and movement in paralytic patients. The ability to acquire signals, analyze, and translates them into commands that are relayed to an output device to carry out the desired action is further propelling the demand for brain computer interface devices, which in turn is driving the growth of the market.
Buy Now
Neurorehabilitation Devices Market Segmentation Analysis- By Disease
The Neurorehabilitation Devices Market-based by Disease can be further segmented into Stroke, Multiple Sclerosis, Cerebral Palsy, Parkinson’s Disease, and Others. The Stroke segment held the largest share in 2021 and is also estimated to be the fastest-growing segment with a CAGR of 16.5% over the period 2024–2030. The growth in this segment is owing to the factors such as the growing focus by the healthcare companies to develop new solutions for the treatment of stroke, the rise in the prevalence of stroke among the people suffering from lifestyle diseases, and the growing aging population. Growing guidelines by the health commissions for developing advanced technologies for treating the people suffering from strokes is driving the growth of the Neurorehabilitation Devices Market. Parkinson’s disease segment held the second-largest share in 2021 owing to the factors such as the increase in the government funding for research and development activities for developing new technologies for the treatment of the Parkinson’s disease, rising healthcare awareness among the patients, and growing prevalence of Parkinson’s disease in the developed nations.
Neurorehabilitation Devices Market Segmentation Analysis- By Geography
The Neurorehabilitation Devices Market based on Geography can be further segmented into North America, Europe, Asia-Pacific, South America, and the Rest of the World. North America held a dominant market share of 36% in the year 2021. The growth in this segment is owing to factors such as the growing incidence rate of neurological diseases, the rise in the number of patients suffering from movement disabilities, and technological advancements in electrostimulation and transcranial magnetic stimulation for the treatment of spinal cord injuries. The presence of major players in the region is driving the growth of the market.
Asia-Pacific is estimated to be the fastest-growing segment over the period 2024–2030. The growth in this segment is owing to the factors such as an increase in the awareness coupled with constantly improving healthcare infrastructure, growing strategic initiatives by the key players to expand the operations in the region, increasing incidences of Alzheimer’s and Parkinson’s disease, and the rise in the investment for the research and development activities.
Neurorehabilitation Devices Market Drivers
Technological Advancements in Electrostimulations is a Key Factor in Market Growth.
According to the National Center for Biotechnology Information (NCBI) research in 2019, adding advanced electrostimulation to Standard Wound Care in all wound types increases efficiency by an extra 26.7%. New technologies in electrostimulation for the treatment of spinal cord injuries are enhancing the growth of the neurorehabilitation devices market. Researchers across the world are developing a new multi-electrode to stimulate the spinal cord at different points to improve the patient’s quality of life. This new electrode is capable of deploying diversified electric messages to different fibers of the cord in a targeted and independent manner, which is driving the growth of the Neurorehabilitation Devices Market.
Rise in the Demand for Neuro-robotic Devices is Propelling the Market Growth.
According to The IEEE Robotics and Automation Magazine, the behavior control ability of neuro-robotic devices was approximately 20,000 neurons and nearly 5,00,000 synaptic connections, and also all of the are updated in real-time to keep up with the active sensors. Neuro-robotic devices combined with neuroscience and rehabilitation became the standard method in the treatment of neurological disorders as it provides different ways of treatment, depending on the specific function to be restored. The technological advancements in robotics and its combination with neuroscience have led to the emergence of next-generation rehabilitation techniques, which is further propelling the growth of the Neurorehabilitation Devices Market.
Neurorehabilitation Devices Market Challenges
Lack of Effective Training Modalities in the Robotic Devices Is Hampering the Growth of the Neurorehabilitation Devices Market.
According to the Journal of NeuroEngineering and Rehabilitation, Passive training modalities are very less for acute than for chronic subjects with only 24% of the groups of acute trained with these modalities in 2019. Robotic neurorehabilitation is gaining prominence in the neurorehabilitation devices market. With the launch of novel technologies, the key companies are enhancing the capabilities of robots to offer cost-effective solutions in clinical practice. However, the lack of effective training modalities for these robotic devices is acting as a major challenge for the healthcare companies to design robotic devices, which is estimated to reduce the growth of the Neurorehabilitation devices Market.
Neurorehabilitation Devices Industry Outlook
Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the Neurorehabilitation Devices Market. The top 10- Neurorehabilitation Devices Market companies are-
Biometrics Ltd
Bionik Laboratories
Bioxtreme Robotics Rehabilitation
Bioness Inc
Ekso Bionics
Ectron Ltd
Kinestica
Medtronic PLC
Kinova Robotics
Hocoma AG
Recent Developments
In February 2022, MindMaze, a neurotherapeutics company secured a USD 105 million financing round to accelerate its commercial growth plans, enhance ongoing R&D and consolidate the clinical development pipeline of its digital therapeutic solutions for various neurological diseases.
In November 2019, Ekso Bionics Holdings has launched the EksoNR, the next generation of its EksoGT robotic exoskeleton, developed for neurorehabilitation purposes. It is an intuitive exoskeleton that empowers patients recovering from stroke and other conditions to learn to walk again with a more natural gait. These features and software enhancements are aimed to get more out of rehabilitation sessions.
In January 2019, Bionik Laboratories has launched InMotion Connect to target the clinical need and improve technology and update the traditional neurorehabilitation process to increase the return on assets. These systems are used for the clinical rehabilitation of stroke survivors. These improved generation InMotion ARM/HAND were developed based on the same principles of neuroplasticity.
For more Lifesciences and Healthcare related reports, please click here
0 notes
healthcarehubhh · 5 months ago
Text
The brain health devices market will grow at highest pace owing to increasing awareness of brain related diseases and technological advancements in diagnostics devices
Tumblr media
Brain health devices aid in the diagnosis and treatment of brain related disorders by leveraging technologies like electroencephalography (EEG), magnetoencephalography (MEG), transcranial magnetic stimulation (TMS), and intracranial pressure monitoring (ICP). These devices help understand patterns of neuronal activity, functional connectivity, and brain dynamics. The BrainScope Company's portable EEG device analyzes brain waves and classifies them to help diagnose brain injuries and concussions within minutes. Brain health devices are increasingly being used in hospitals, neuro laboratories and clinics to gain meaningful insights and devise personalized treatment plans for patients suffering from Alzheimer's, Parkinson's, epilepsy, strokes and dementia. The Global Brain Health Devices Market is estimated to be valued at US$ 9,070.5 million in 2024 and is expected to exhibit a CAGR of 7.7% over the forecast period 2023 to 2030. Key Takeaways Key players operating in the brain health devices market are BrainScope Company, Inc., Bio-Signal Group Corp., Cadwell Industries, Inc. Advanced Brain Monitoring, Inc., Compumedics Ltd., Elekta, DePuy Synthes, Electrical Geodesics, Inc., Medtronic, GE Healthcare, MEG International Services Ltd, Natus Medical, Inc., Neurowave Systems Inc., Nihon Kohden Corporation, and Philips Healthcare. Growing awareness regarding various brain related diseases and disorders is expected to propel the demand for brain health devices over the forecast period. Technological advancements are enabling high resolution scanning of brain structural and functional connectivity networks through lightweight and portable devices. Market Trends Portable and Home-Use Devices: Growing demand for convenient medical devices is prompting manufacturers to develop portable and wireless EEG, MEG, TMS and ICP monitoring equipment that can be used at home. This makes treatment accessible and inexpensive. Artificial Intelligence Integration: AI and machine learning techniques are finding widespread usage in brain data analysis. Devices are being integrated with AI capabilities to offer real-time diagnostics, automated report generation and personalized treatment recommendations. Market Opportunities Paediatric Applications: Brain monitoring and therapeutic devices tailored for infants and children can help diagnose developmental delays and disorders early. This presents lucrative opportunities. Emerging Markets: There is significant untapped growth potential in developing regions of Asia Pacific, Latin America, Middle East and Africa driven by rising healthcare expenditures and increasing incidence of neurological conditions. Impact of COVID-19 on Brain Health Devices Market The COVID-19 pandemic has accelerated the growth of the brain health devices market. Hospitals and diagnostic centers witnessed a surge in demand for brain monitoring devices due to the rising number of COVID-19 patients. Neurological complications were prevalent among severe COVID cases, necessitating effective brain monitoring. Further, risk factors of strokes and mental health issues increased amid lockdowns and social isolation, propelling the need for brain health management devices for diagnosis and treatment. The pandemic led to challenges in the supply chain and distribution channel initially. However, companies introduced new product lines specific to COVID care and virtually connected healthcare models utilizing brain health devices. The focus on portable, home-used devices for conditions like alzheimers, dementia, headaches, and insomnia aided market prospects. Telehealth emerged as an efficient mode to serve patients from remote locations as they avoided visits to crowded hospitals, especially during the peak pandemic periods.
0 notes
mymedtrips · 6 months ago
Text
Best Neurosurgery Hospitals in India
Neuro diseases are very bad diseases. Many people are caught by Neuro diseases nowadays. It is related to brain diseases. Many people in India are caught by Neuro Diseases. It happens in Adults as well as children.
A person of any age can be affected by this. Before this time very bad disease Named EPILEPSY affected adults as well as children. It causes FITS in a person who is affected by this disease. It is a nerve problem in the Brain.
When this disease increases it can become BRAIN TUMOR in a person who is affected by this disease which can be the cause of death. It is not good for a person and their family members.
When a person is affected by BRAIN TUMOR then firstly doctors recommend to treatment of a person by medication. The person affected by the starting phase of BRAIN TUMOR of many diseases like EPILEPSY and the person has to take many medicines in a day for many years, Medicine Neuro diseases are very costly. But if a person doesn't want to do surgery on the brain, a person is afraid of death. So a person is ready to take medicines daily.
otherwise, in BRAIN tumors doctors recommend doing Neurosurgery of the Brain. Doctors check that person who has been taking medicines for many years and then suggest him to Neurosurgery or take medicines his whole life.
Neuromedicines and neurosurgery a very costly processes in India and it is very tough to take treatment of NEUROSURGERY for a Normal middle-class person. A person doesn't want to prefer surgery so he recommends taking medicine and the person's family members don't agree to Neurosurgery.
NEUROSURGERY COST in India
When a Patient's Condition is very critical then doctors suggest Neurosurgery. There are many tests of the brain recommended by doctors i.e. MRI, CT-Scan, EEG, etc. Which are very costly. MRI confirms that this part of the brain caused of Brain Tumor. It is a very technical surgery and many gadgets are used in this surgery. Most doctors do laser neurosurgery which is very costly and difficult to do by a middle-class person. It starts from 2 lacs to 5 lacs. But for some patients, its amount goes high.
BEST HOSPITAL FOR NEUROSURGERY IN INDIA:
Now in every city, there is a one special hospital named Neurosurgery like Bhatia Neurosurgery Hospital which is in Patiala district in Punjab. Also, many hospitals especially do treatment of this disease and other diseases as well like Knee Surgery. Other hospitals are popular for the treatment of Neurosurgery like Indraprastha Apollo Hospital in New Delhi. Fortis Healthcare is situated in almost every state of India. Apollo is the best neurosurgery hospital in India.
BEST DOCTORS FOR NEUROSURGERY IN INDIA
There are many doctors of Neurosurgery in India. In every government hospital, there are many special neurosurgeons do treatment of Neuro patients. Some Doctor's name I am mentioning below.
1. Dr. Sudheer Kumar Tyagi
2. Dr. Vinit Suri
3. Dr. V.P. Singh
4. Dr. Sanjeev Dua
5. Dr. Anita
My Med Trip is one of the best medical tourism companies. We provide complete medical and healthcare services with consulting in India for patients from all over the world including South African countries like Kenya, Ethiopia, South Africa, etc. We help you in finding the best hospitals, doctors, and good accommodations at affordable costs in India. We offer Kidney, liver, lung, heart, and bone marrow transplants and treatment; shoulder replacement surgery cost , knee replacement surgeries, breast cancer surgery cost, skin cancer treatment, kidney transplant cost, heart transplant and so on.
Source: https://mymedtrips.blogspot.com/2023/09/best-neurosurgery-hospitals-in-india.html
0 notes
bhushans · 6 months ago
Text
Global Focus on Improved Outcomes: Global Neuro Immunoassay Market
The global neuro immunoassay market is poised for remarkable expansion, with projections indicating a surge to USD 5,303.1 million by 2033, according to recent market analysis. This forecast marks a substantial increase from its 2023 valuation of USD 2,616.1 million, reflecting a robust Compound Annual Growth Rate (CAGR) of 7.3% during the forecast period.
Neuro immunoassay, a vital segment within the healthcare industry, plays a pivotal role in diagnosing and monitoring neurological disorders and autoimmune diseases. With advancements in technology and an evolving understanding of these conditions, the demand for accurate and efficient diagnostic tools is on the rise. Neuro immunoassay techniques offer a precise and reliable means of detecting biomarkers associated with various neurological and autoimmune conditions, driving their adoption across clinical settings worldwide.
Initiate In-Depth Research With Your Sample: https://www.futuremarketinsights.com/reports/sample/rep-gb-4293
The projected growth of the neuro immunoassay market underscores the increasing prevalence of neurological disorders and autoimmune diseases globally. As populations age and lifestyles evolve, the incidence of these conditions continues to escalate, necessitating advanced diagnostic solutions for timely intervention and management.
Key Takeaways:
The global neuro immunoassay market is expected to reach a value of US$5,303.1 million by 2033, reflecting a significant increase from US$2,616.1 million in 2023.
This growth is projected at a healthy compound annual growth rate (CAGR) of 7.3% during the forecast period.
The surge in demand is attributed to the crucial role of immunoassays in various applications like biopharmaceutical analysis, clinical diagnostics, and early disease detection.
Key Segments of the Neuro Immunoassay Market
By Technology:
Radioimmunoassays (RIA)
Polymerase Chain Reaction (PCR)
ELISA
Western Blot
Rapid Tests
ELISPOT
By Product Type:
Reagents and Kits
Analysers
By Application:
Alzheimer’s Disease
Parkinson’s Disease
Huntington’s Disease
Amyotrophic Lateral Sclerosis (ALS)
Spinal Muscular Atrophy (SMA)
By End User:
Hospitals
Clinics
Academic Organizations
Biopharmaceutical Companies
Pharmaceutical Companies
Others
By Region:
North America
Latin America
Asia Pacific
Middle East and Africa
Europe
0 notes
jayanthitbrc · 7 months ago
Text
Visualizing Growth: The Rising Demand for Angiography Equipment in the Market
Overview and Scope The angiogram equipment examine blood vessels as well as to view a person's internal organs. The process involves injecting a radio-opaque contrast agent into the bloodstream of the patient and creating the image using X-ray-based methods. Sizing and Forecast The angiography equipment market size has grown strongly in recent years. It will grow from $12.47 billion in 2023 to $13.41 billion in 2024 at a compound annual growth rate (CAGR) of 7.5%.  The  growth in the historic period can be attributed to rising cardiovascular diseases, minimally invasive procedures, aging population, healthcare infrastructure development, clinical research and development.. The angiography equipment market size is expected to see strong growth in the next few years. It will grow to $17.95 billion in 2028 at a compound annual growth rate (CAGR) of 7.6%.  The growth in the forecast period can be attributed to integration with hybrid ors, data security and privacy, globalization of healthcare services, patient-centric care, personalized healthcare. To access more details regarding this report, visit the link: https://www.thebusinessresearchcompany.com/report/angiography-equipment-global-market-report Segmentation & Regional Insights The angiography equipment market covered in this report is segmented – 1) By Product: Angiography Systems, Angiography Catheters, Angiography Contrast Media, Vascular Closure Devices (VCDs), Angiography Balloons, Angiography Guidewires, Angiography Accessories 2) By Technology:  X-Ray Angiography, CT Angiography, MR Angiography, Other Technologies 3) By Procedure: Coronary Angiography, Endovascular Angiography, Onco-Angiography, Neuro-angiography, Other Procedures 4) By End User: Hospitals And Clinics, Diagnostic And Imaging Centers, Research Institutes Europe was the largest region in the angiography equipment market share in 2023. The regions covered in the angiography equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. Intrigued to explore the contents? Secure your hands-on sample copy of the report: https://www.thebusinessresearchcompany.com/sample.aspx?id=8217&type=smp Major Driver Impacting Market Growth The rising frequency of cardiovascular illnesses is expected to drive the angiography equipment market. Cardiovascular disease (CVD) system uses X-ray pictures to detect cardiac blood arteries that are obstructed or constricted. Key Industry Players Major companies operating in the angiography equipment market report are General Electric Company, Koninklijke Philips N.V., Siemens Healthineers AG, Canon Corporation, Boston Scientific Corporation, Cordis Corporation, Shimadzu Corporation, Medtronic plc, Angiodynamics, B. Braun Melsungen, Abbott Laboratories, Terumo Corporation The angiography equipment market report table of contents includes: 1. Executive Summary 2. Market Characteristics 3. Market Trends And Strategies 4. Impact Of COVID-19 5. Market Size And Growth 6. Segmentation 7. Regional And Country Analysis . . . 27. Competitive Landscape And Company Profiles 28. Key Mergers And Acquisitions 29. Future Outlook and Potential Analysis Contact Us: The Business Research Company Europe: +44 207 1930 708 Asia: +91 88972 63534 Americas: +1 315 623 0293 Email: [email protected] Follow Us On: LinkedIn: https://in.linkedin.com/company/the-business-research-company Twitter: https://twitter.com/tbrc_info Facebook: https://www.facebook.com/TheBusinessResearchCompany YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ Blog: https://blog.tbrc.info/ Healthcare Blog: https://healthcareresearchreports.com/ Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
0 notes
rohans18 · 1 year ago
Text
Neuro-Behçet’s Disease Treatment Market Expected High Growth in Coming Years
Global Neuro-Behçet’s Disease Treatment Market, By Symptoms (Brainstem Syndrome, Multiple-Sclerosis like Presentations, Movement Disorders, Meningoencephalitic Syndrome, Myelopathic Syndrome, Cerebral Venous Sinus Thrombosis (CVST), and Intracranial Hypertension), Forms (Parenchymal and Non-Parenchymal), Treatment (Corticosteroids, Immunosuppressive Agents, Immunomodulators, Phosphodiesterase 4 (PDE4) Inhibitor, Interleukin-1β blocker and Others), Route Of Administration (Oral, Injectable), End Use (Hospitals, Homecare, Specialty Clinics, Others), Country (U.S., Canada, Mexico, Peru, Brazil, Argentina, Rest of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia Pacific, South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of the Middle East and Africa) Industry Trends and Forecast to 2028
An expert team performs systematic, object-oriented and complete market research study to provide the facts associated with any subject in the field of marketing via Neuro-Behçet’s Disease Treatment marketing report. The report has a lot to offer to both established and new players in the Neuro-Behçet’s Disease Treatment industry with which they can completely understand the market. SWOT analysis and Porter’s Five Forces analysis methods are used wherever applicable, while generating this report. One of the most important parts of an international Neuro-Behçet’s Disease Treatment market report is competitor analysis with which businesses can estimate or analyse the strengths and weaknesses of the competitors.
Key Players
The major players covered in the Neuro-Behçet’s Disease Treatment market report are Medtronic, Angiotech, BetaGlue, Teleflex Incorporated, Abbott, Smiths Group plc., ATMOS MedizinTechnik GmbH & Co. KG, Sinapi Biomedical, Nobelpharma Co., Ltd, Vygon, Zebra Medical Vision, Inc., Allergan, Merck Sharp & Dohme Corp., Pfizer Inc., GlaxoSmithKline plc, F. Hoffmann-La Roche Ltd., Mylan N.V., Teva Pharmaceutical Industries Ltd., Sanofi, Novartis AG, Bayer AG, Sun Pharmaceutical Industries Ltd., Aurobindo Pharma, Lupin, Eli Lilly and Company, among other domestic and global players.  Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
 Browse More Info @ https://www.databridgemarketresearch.com/reports/global-neuro-behets-disease-treatment-market
With the help of credible Neuro-Behçet’s Disease Treatment market analysis report, businesses can make out the reaction of the consumers to an already existing product in the market. The report includes estimations of recent state of the market, CAGR values, market size and market share, revenue generation, and necessary changes required in the future products. A wide-ranging competitor analysis helps build superior strategies of production, improvement in certain product, its advertising or marketing and promotion for the business. Exhaustive and comprehensive market study performed in the wide ranging Neuro-Behçet’s Disease Treatment market report offers current and forthcoming opportunities that put light on the future market investment.
Key questions answered in the report:
Which product segment will grab a lion’s share?
Which regional market will emerge as a frontrunner in coming years?
Which application segment will grow at a robust rate?
Report provides insights on the following pointers:
Market Penetration: Comprehensive information on the product portfolios of the top players in the Neuro-Behçet’s Disease Treatment Market.
Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and product launches in the market.
Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the market.
Table Of Content
Part 01: Executive Summary
Part 02: Scope Of The Report
Part 03:  Global Market
Part 04: Global Market Size
Part 05: Global Market Segmentation By Product
Part 06: Five Forces Analysis
 More Reports:
Diuretic Drugs Market
Patient Engagement Technology Market
Healthcare Business Intelligence Market
Chinese Hamster Ovary cells (CHO) Market
Anti-cancer Drug Market
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
0 notes
alswarriorsa · 1 year ago
Text
Genesis
It all started with a twitch. A simple little muscle tremor in my left arm, near my bicep.
I can’t recall exactly when in 2022 it started, but it was in May that I finally decided that “stress” was not the right self-diagnosis.
By May, it wasn’t just one twitch. It was a wave of twitches, same arm, with a pinky finger tremor. My GP referred me to a neurologist, with a month and a half waiting period - however, she insisted it would be worth the wait.
In August 2022, after X-rays and scans, and with the way my symptoms presented, I was diagnosed with early-onset Parkinson’s disease. That diagnosis alone felt life changing, yet in hindsight was nothing close to the reality that would eventually close in on me.
I immediately started researching, reading everything I could, and started sharing my journey online, advocating for awareness around Parkinson’s… but after a few months, my symptoms just weren’t adding up or making sense.
By December 2022 I could no longer use my left hand or arm, at all. I had given up riding a motorcycle, playing guitar and even an instructor career in scuba diving.
After attempts to secure a follow-up appointment with my neurologist were unsuccessful due to availability, it was a stiff and painful left wrist that pushed me into the ER at a nearby hospital, that would change my life.
Late March 2023, I was given a thorough examination and neuro conduction study which provided the final answer - motor neurone disease.
I’m still sharing my journey online, and still advocating for awareness, but the harsh reality is that this disease is fatal and that South Africa is estimated to be 25 years behind the rest of the world in terms of health insurance benefits and clinical trials.
This isn’t just hard on me. It’s hard on everyone around me.
I’m hopeful that by sharing my experience and this journey, I’ll somehow be able to contribute to awareness and the fight to #endals.
1 note · View note
healthcaremarketfmi · 2 years ago
Text
Home Rehabilitation Services Market New Technological Development Projecting Massive Growth till 2032
[250 Pages Report] According to Future Market Insight’s latest analysis, the global home rehabilitation services market was valued at over US$ 84.1 Bn in 2021 and is expected to exhibit a CAGR of close to 4.8% over the forecast period (2022-2032).
The home rehabilitation services market is witnessing a high demand owing to the rising prevalence of chronic disease, surge in the population with disability and the increase in the number of baby boomers.
According to the World Health Organization, more than 1 billion people in the world live with disability. Some health conditions associated with a disability will result in poor healthcare needs. In most parts of the world, people with disabilities face extreme barriers while accessing health and rehabilitation services.
It is critical for home care patients to not only identify each subject’s stimuli, incorporate them into everyday life, and increase the number of times in training, but also to observe tenderly and attend with sympathy. Such a strategy would alleviate a subject’s worry while also providing motivation and peace of mind.
The increased awareness of the benefits of home rehabilitation services among physicians and patients and rising trend of home healthcare government support and initiative and the increasing adoption of telerehabilitation and e-health will provide even more attractive potential for market expansion.
“Increasing popularity of telehealth services, along with growing demand for ortho rehabilitation will augment the growth in the market over the assessment period,” says an FMI analyst.
Key Takeaways:
Sales in the ortho rehabilitation segment are forecast to increase at a 5% CAGR over the assessment period.
The U.S. will dominate the North America home rehabilitation services market and held 92.8% of the total market share in 2021.
Demand for home rehabilitation services in China will grow at a 5% CAGR through 2032.
Australia will emerge as a lucrative pocket, with demand growing at a 4.6% CAGR over the forecast period.
For more Information: https://www.futuremarketinsights.com/reports/home-rehabilitation-services-market
Competition Landscape
Key service providers are collaborating at all levels of the health system to develop technical, policy, and research capability, as well as increase political commitment and inspire leadership.
Various manufacturers are also utilising modern technologies and supporting simple, low-cost service delivery methods to provide access to rehabilitation in the home and community, which is where it is most needed. For instance:
In late 2020, ReLAB-HS launched a five-year initiative adapted to satisfy the growing need for physical rehabilitation services in low- and middle-income countries.
Key Market Segments Covered in Home Rehabilitation Services Industry Research
By Service Type:
Ortho Rehabilitation
Neuro Rehabilitation
Cardiopulmonary Rehabilitation
Geriatric Rehabilitation
Others
By Region:
North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East and Africa (MEA)
Which Factors are Restraining the Demand for Home Rehabilitation Services?
Despite the growing scope of services in the developed countries, home tele-rehabilitation services tend to face many challenges across developing economies. Factors such as the lack of physician skills required in e-health, apprehensions associated with data privacy, and the dearth of national e-health policies, will hinder the growth in the home rehabilitation services market.
Most of the healthcare professionals are not well acquainted with the latest information technologies, and also find it difficult to handle modern gadgets. There is a lack of telemedicine experts in many developing countries, which can hamper demand for home rehabilitation services.
More Insights into Home Rehabilitation Services Market Report
Future Market Insights brings a comprehensive research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2017 to 2032.
The global home rehabilitation services market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. The study provides compelling insights on the home rehabilitation services market segment based on   By services– (ortho rehabilitation, neuro rehabilitation, cardiopulmonary rehabilitation, geriatric rehabilitation, and others), and across seven major regions.
0 notes
reportsneww · 2 years ago
Text
Vascular Embolization Market size 2023 to 2031
Newark, New Castle, USA - Growth Plus Reports' most recent study examines the Global Vascular Embolization Market's production, prospective uses, demand, key companies, and SWOT analysis.
The Vascular Embolization Market Report will help you determine the best distribution strategies for specific products and identify potential markets. In addition, the report examines the purchasing and supply patterns that impact the market. The Vascular Embolization market research report provides insights into the limitations, market trends, prospects, drivers, and competition in the Vascular Embolization sector.
You may get insights into the TOC, and Statistics for essential facts, information, trends, and competitive landscape information.
Download Free Sample Report Now @ https://www.growthplusreports.com/inquiry/request-sample/vascular-embolization-market/8433
The following are the leading companies in the Global Vascular Embolization market:
Abbott Laboratories
Medtronic Plc
Boston Scientific Corporation
Stryker Corporation
Terumo Corporation
Cook Medical
Shape Memory Medical Inc.
Penumbra Inc.
Merit Medical Systems Inc.
Braun Melsungen AG
L. Gore & Associates Inc.
Microvention Inc
Codman Neuro
Growth Plus Reports studies the key trends in each category and sub-segment of the Vascular Embolization market, along with Global and regional projections from 2023 to 2031. Our research splits the market into product type and application segments.
SEGMENTATION
GLOBAL VASCULAR EMBOLIZATION MARKET - ANALYSIS & FORECAST, BY TYPE
Coiling Devices
Non-Coiling Devices
GLOBAL VASCULAR EMBOLIZATION MARKET - ANALYSIS & FORECAST, BY APPLICATION
Oncology
Peripheral Vascular Diseases
Neurology
Urology
Others
For More Information or Query or Customization visit: https://www.growthplusreports.com/inquiry/customization/vascular-embolization-market/8433
Companies may utilize Vascular Embolization market report to get insights on market variables and any restraints that may affect the manufacturing of their product. Companies that are expanding abroad require thorough Global market research that includes real market data to assist with their marketing strategy. This Global market Vascular Embolization industry study analyzes important market dynamics and provides in-depth information and statistics to help companies flourish. This research report on the Vascular Embolization market takes advantage of advanced and professional approaches such as SWOT analysis and GRG Health's unique GrowthMIX strategy.
This report is useful in addressing various essential issues for market participants, while also supporting them in making investments and leveraging the market opportunities.
Vascular Embolization Market TOC: https://www.growthplusreports.com/report/toc/vascular-embolization-market/8433
Market segment by Region/Country including: –
-North America (United States, Canada and Mexico) -Europe (Germany, UK, France, Italy, Russia and Spain etc.) -Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.) -South America (Brazil, Argentina and Colombia etc.) -Middle East and Africa (South Africa, UAE and Saudi Arabia etc.)
0 notes
silverlab101 · 2 years ago
Text
Water Purification Drops 30ml Mms Bio-sil South Africa
She was starting to seem like a healthy lioness once more. The paws have been then bandaged as a lot as enable the healing process to start. The uncooked little pads had been treated with Cellskin which is a human product that nourishes, oxygenates and protects the skin. The skin overlaying the paws pads was broken because of solely having concrete to walk on as there was no grass within the enclosure on which to walk. I popped Cell Pet into her bottle from the day I obtained her.
Key advantages of this product is that it helps preserve neuro health, cardiovascular well being and is wealthy in antioxidants. Improves mind function, memory, focus and mental readability. Helps maintain wholesome imaginative and prescient and improves blood circulate to the extremities. Ginkgo Biloba improves focus, memory, lack of power and depressive temper disorders.
Chamomile can also be a helpful anti-inflammatory, analgesic and anti-spasmodic. As a rule most herbs should not be fed to pregnant animals, as lots of then have uterine or hormonal stimulant properties. Before feeding a herb to a broodmare or foal, please seek the assistance of with a herbalist to have the ability to substantiate safety of a selected herb. When feeding dried natural blends, a most colloidal silver for stomach problems every day dose of 30-50g is adequate for a horse, and the dosage must be halved for ponies. Since the Nineteen Seventies, medicine containing platinum — the rarest and most treasured metal — have been used to treat testicular and ovarian cancers. Now other types of the disease have been added to the list.
Colloidal silver is the number one anti-fungal, anti-bacterial and anti-viral. It is as potent as a critical drug, without the dangerous side effects. Just make sure to complement with a Pro-Biotic at the identical time, yoghurt or Kombucha. Barbara, being pores and skin and bones at all costs is your alternative.
So as funds go I had to wait abit longer than my mother to purchase this product, this morning my mother phoned me and stated it seems like she is dying. She has been using this nut for 3weeks now at first it was good, she had a traditional colloidal silver for stomach ulcers bowl motion something she have been battling for years. She has no energy, sleeping all day and don't have any appitite. Luckily she decided to stop with this “wonder” nut.
Within a couple of minutes, the pathogen suffocates and dies and is cleared out of the body by the immune, lymphatic and elimination techniques. Unlike pharmaceutical antibiotics which destroy useful enzymes. Colloidal Silver leaves these tissue-cell enzymes intact, as they're radically completely different from the enzymes of primitive single-celled life. Thus Colloidal Silver is totally protected for humans, animals, crops and all multi-celled dwelling organisms. We use this as our go-to pure fast repair for all our family ailments from combating the onset of flu infections to would healing, as a pores and skin toner and general immune booster for the whole household pets included. Sorts out mouth infections, infected eyes, pores and skin wounds, and heaps of others.
We also add Cell-Vet to the water given to the older monkeys. When for example, a monkey is torpid, we simply add Cell-Vet to their rehydration and the distinction is very noticeable inside a short time. We have been so impressed with the end result, that we've never discontinued using your great product. Riders have been known colloidal silver stomach ulcers to rise up every hour through the freezing nights to verify on their horses. It isn't the hardest because of the space, but as a end result of riders must full long distances over three consecutive days.
0 notes
mymedtrips · 11 months ago
Text
Neurosurgery in India
Neurosurgery is commonly known as brain surgery. Neurosurgery treats nervous system related problems. The peripheral nervous system is composed of the nerves that connect the brain and spinal cord to the rest of the body.
There are several types of brain surgeries such as:
Craniotomy- This type of surgery is done to remove brain tumors, an aneurysm, drain out blood or infection from an infection, or remove any abnormal brain tissue.
Biopsy- It removes some brain tissues or tumors for detecting them under microscope.
Deep brain stimulation- In this type of surgery, an electrode is placed inside the brain for transmitting electrical signals.
 Best Neurosurgery doctors in India
India is known for its medical facilities. Anyone can also find best doctors for neurosurgery in India. Among all neurosurgery doctors, some of the best neurosurgery doctors in India are given below-
Dr. K Sridhar
Dr. Aditya Gupta
Dr. Sudhir Tyagi
A brain surgery is essential to repair structural problems in our brain. It can be due to birth defects, diseases, injuries, etc. Such conditions that require neurosurgery are:
Aneurysms
Blood clots
Parkinson’s disease
Stroke
Brain tumors
Nerve damage
Neuro-oncology: It focuses on tumors of the brain and the spinal cord.
Functional Neurosurgery: This type of surgery helps to treat problems such as movement disorders, cerebral palsy and epilepsy.
Neurovascular Surgery: It focuses on the blood vessels that supply the nervous system and their related problems such as narrowing, aneurysms, etc.
Traumatology: A neurosurgeon who has done specialization in traumatology treats injuries to the nervous system, such as head injuries, surgically.
Spinal Surgery: It focuses on surgeries of the spinal cord.
Skull-base surgery: Neurosurgeons in this field specialize in anomaly surgeries which is present at the skull base.
Best Neurosurgery hospital In India
As per the treatment, one can find the best hospitals for neurosurgery in India. But among such health care centres, some of the best neurosurgery hospitals in India are as follows.
Global hospital, Chennai
Artemis hospital, Gurgaon
MIOT International, Chennai
Some commonly prescribed tests for neurological problems are-
Imaging such as MRI, CT scan, etc.
Blood and Urine test
Electroencephalogram
Electromyogram
 Nerve or Muscle Biopsy
Neurosurgery cost in India
The average neurosurgery cost in India is between 2,50,000 to 3,50,000. The total neurosurgery price in India depends on the diagnosis and facilities decided by the patient.
The cost of neurosurgery in India includes:
Surgery cost
Pre-operative diagnostic test cost
Post-operative cost
Medicine cost
Patient’s hospital stay
The price of neurosurgery in India is expensive, but preventable sometimes. Most neurological problems are not preventable. Some basic guidelines everyone should follow that managing all chronic conditions such as diabetes and high blood sugar under medical supervision. It is important to prevent neurological problems.
My Med Trip is one of the best medical tourism companies in India. We provide complete medical and healthcare services with consulting in India for patients from all over the world including South African countries like Kenya, Ethiopia, South Africa, etc. We help you in finding the best hospitals, doctors, and good accommodations at affordable costs in India. We offer Kidney, liver, lung, heart, and bone marrow transplants and treatment; shoulder replacement surgery cost in India, knee replacement surgeries, bone marrow transplant cost in India, heart replacement, top heart hospital in India, knee replacement, best Kidney transplant hospital in India and so on.
Source:  https://mymedtrips.blogspot.com/2023/08/neurosurgery-in-india.html
0 notes
polyamorouspunk · 2 years ago
Text
I really try and focus on my followers for my sleepover fridays because I like talking to you but I kind of just need to get my thoughts out rn so please excuse me and feel free to ignore.
The idea of maybe going to med school is kind of a trip. I mean the other day when I got a 98 on my test I started to realize maybe I could and like should I go into nursing because on places like tumblr you hear all these horror stories of being treated like shit by cishet nurses and how people want doctors and nurses who “look like them” (aka POC, queer people, fat people, etc. people they can relate to besides the image of an upper class white girl) and I’m like maybe I should do that and later that day I ended up talking about what I did want to go into and I realized this is my passion and I really want to persue this.
But my OTHER passion really is infectious diseases and I always said to myself “well I’m going into psychology because I can’t go into med school” and I always had an excuse, you know as a kid it was “well I want to be a vet but I have a fear of needles so I can’t do that” and then it was “well I’m bad at math so I can’t go into med school” and now it’s like “well I’m going into psychology so I don’t need to go into med school” but like. I’m interested in the medicalized side of psychology. I don’t really care to sit in a room and have people tell me their problems, though I’m totally fine with that, and I’m thinking maybe when I’m older like 50s that might be good to like “retire” into, what I want to do is find out WHAT causes pedophilia and HOW we can try and stop CSA from that angle. Like I want to go into prisons and be the Mindhunter but with pedophiles instead of serial killers. I want to look at scans of their brain and find out what’s different from you or me- if there even is anything. And honestly we may already know all this (last time I did a paper on pedophilia was like 2018 so that was 5 years ago and of course in medical terms 5 years ago is already outdated for some things) but more research isn’t going to hurt. Like you can’t have too much research. And I wouldn’t even mind being some sort of therapist for child victims of CSA to hear their side of things too.
But I love, love, love infectious diseases. I’ve had a lot of people tell me I should go into English and be an author or a teacher because I’m “good at it” and I’m like yeah but I have no interest in making a career out of it, and I’ve had people tell me I should go into epidemiology and I go yeah but I’m not smart enough to or I would. But like. Maybe I am. Like honestly maybe I could. And there’s totally ways out there to combine my love of psychology and epidemiology. Like I just answered in @/safety-pin-punk’s ask (go follow) I just saw an interview with a neuro-something psychologist talking about the effects of true crime and why people love it (very complicated reasoning but I’m one of those people [who RESPECTFULLY consumes true crime]) and it’s like if you’re a neuro-something you need to have some medical training. Not really sure pedophilia and infectious diseases really fit together besides like I know you can literally “become a pedophile” after a head injury so it’s not that far of a reach to say you can “become a pedophile” if some sort of infectious disease messes with your brain but like. I mean honestly for years the dream has been to like be a forensic anthropologist (I LOVE Bones, that show influenced me a LOT) and then kind of switched towards like loving epidemiology and like honestly yeah sometimes I day-dream about being able to work in Hot Zones and be on the ground in Africa combating Ebola outbreaks I mean MAN what a dream but like… it was always a dream, you know? Not a reality. Like I read The Hot Zone and I was like oh my god this is SO COOL and like I watch WAY too many Outbreak-type movies because they are my favorite genera of movie besides war movies (Contagion? 28 Days Later? Literally any zombie out break movie ever? LOVE LOVE LOVE). And like *flaps hands* AH I just love that shit but like fuck man. Idk. Idk. Like obviously I’m going to start looking into what it takes to actually really do that which is just… something I never did because I never seriously entertained the idea beyond a dream. I just don’t know. I love both ideas. I had picked psychology because it was easier and I didn’t think I could do epidemiology. But maybe I can.
Edit: yeah like you need like a fucking doctorate and I’m like do I really want to go and get a doctorate or should I just settle for psychology-
Edit 2: I might need a doctorate for psychology research anyway so like fuck man idk maybe I should just work in retail until I’m 65-
(Also my mom keeps telling me this is why I need an advisor, I do not have a good college advisor, she didn’t even register me for my classes, some random guy did 😑)
So I guess I really need to talk to an advisor yeah 😑
Edit 3: like if I already need a doctorate for psychology should I just say fuck it and switch idk yk? I would have to redo a lot of schooling though because I’ve tailored my classes as best I could to psychology but like at the end of the day I’m only getting a BA in Arts. Man I need an advisor skhdkdhsjs.
15 notes · View notes
punksarahreese · 4 years ago
Text
Blue | La Douleur Exquise
Nosdecember day 24 | @neworleansspecial
Hanahaki!AU; Sarah starts suffocating on her flowers at work
CW: Hanahaki disease, vomiting/coughing up blood, medical gore, child abuse mention
***
“Doctor Bekker?” Sarah called from where she stood by the nurse’s station. Ava was in treatment one with a patient, though she looked up at the call of her name. She must have excused herself to the patient’s family because soon she was standing in front of Sarah and the resident had to force a polite smile.
“You paged?”
“Oh, yes,” Ava passed her a tablet with a chart pulled up, “A girl came in with an arrhythmia, presumably from an undiagnosed heart condition. She flinches every time I move and is anxiously looking at her father for his consent before speaking.”
“So you’re thinking abuse?”
“Looks that way, I figured a shrink would know best.”
Sarah nodded, ignoring the way her chest clenched a little when the surgeon leaned a bit closer to zoom in on something on her chart. She knew by then that she was suffering from Hanahaki disease, caused by Ava herself, but she hadn’t told anyone. She felt foolish, knowing she should make an appointment with a specialist and schedule a removal surgery. Still, she hadn’t let herself even humour the thought. Removing her flowers would mean tearing out every feeling she had for Ava. She knew this would kill her in the end but she couldn’t bring herself to kill it first, not yet.
“A history of broken bones and her x-ray today showed calcifications on her ribcage that suggest untreated rib fractures.”
“Poor kid,” Sarah mumbled as she looked over the x-ray Ava pointed out, “You want me to speak with her or the parents?”
“I’ll deal with them, take them to sign something. You talk to the girl, just be gentle; she’s scared”
“Of course,” Sarah couldn’t help the sigh of relief when Ava left to go escort the parents to a conference room, feeling the pressure in her chest ebb away. She had quickly learned that the closer she was to the subject of her affections, the more pain her flowers caused. She had done research on the petals she had begun coughing up weeks ago, unnerved by the blood speckling the pink and purple flowers she didn’t recognize. Barberton daisies, google claimed, were native to South Africa. That made sense, especially since Hanahaki was often characterized by flowers significant to the patient’s love interest. Daisies were beautiful, they used to be one of Sarah’s favourite flowers, but now that she had seen far too many covered in her own blood she had begun to hate them.
With Ava out of the room, Sarah had no problem sitting down with their patient. The girl was no older than seven, far too young to be exposed to any type of violence. She was scared, that was obvious, and it took a fair amount of coaxing before she would speak to Sarah. Slowly, the psychiatrist did get her to open up and she hid behind her hands as she told her the truth in a hushed whisper. Her dad got angry, she explained, and mom wasn’t much better. She was punished for many things, pointing out her most recent bruise; a big red welt across the back of her thighs.
“I didn’t finish my dinner…” she admitted softly, as though she was afraid Sarah too would punish her for that. The doctor immediately reassured her that she did nothing wrong, waving in a nurse to call child-family services as soon as possible.
Sarah should have paid more attention, because it was at that moment that the girl’s father returned to the treatment room. He must have heard her ask Monique to make the call, since it wasn’t before long that the room was full of yelling.
“You stay out of my family’s business, bitch!” he was yelling at Sarah, quickly having her backed against the wall. When Sarah cried out because she ran into the sharps container mounted on the wall, Ava had already walked into the room. Mo ran off to call security, all of them worried about what this man was capable of. The patient was in tears, shrieking at her dad to leave the nice doctor alone because it wasn’t her fault. Ava had the guy’s hand pinned behind his back the second he looked ready to hit Sarah, dragging him towards the door.
“Don’t you dare lay a hand on her, Mr. Klein,” she spat, “Or you will be escorted off the premises.”
That had the man shouting more expletives at her, cursing out every female staff member in the general vicinity. Sarah had managed to get away from the wall, thanking Ava quietly as she walked back over to the girl. She was breathing heavily, hyperventilating out of fear, and she looked ready to pass out.
“Hey, Lena, you’re safe,” Sarah promised softly, leaning over to turn up the oxygen to ease her breathing. A quick glance at her monitors had her concerned though, her heart rate was skyrocketing and her oxygen stats only decreasing.
“Ava?” she called, not thinking about the way the surgeon preferred to be on a title basis with everyone but Connor. She was too worried, knowing this father had sent his daughter into a panic attack and maybe triggered something more severe.
Doctor Bekker was by her side in seconds, checking the stats herself and calling for an EKG. Her blood pressure was oddly high for a young child, the child having trouble speaking and grabbing at Sarah’s hand for reassurance.
“Lena?” Ava leaned over her with her penlight, “Can you follow this for me?”
Sarah watched as she tried to complete a quick neuro exam, soon realizing that the child’s right pupil was sluggish and not reactive. In seconds Mo was paging a neuro consult, while Ava and Sarah tried to keep the patient calm and awake.
“A stroke?” Sarah rasped, struggling to breathe herself because of how close her and the other woman had been standing while tending to Lena.
“Something like that,” Ava nodded, “Transient ischemic attack maybe? If she’s been abused for a while she could have had an aneurism or bleed that was missed.”
“She’s so little,” Sarah breathed, giving the child’s hand a gentle squeeze when she noticed her eyes falling shut, “Lena, stay with us, honey.”
Sarah wasn’t sure how exactly she made it through the next few minutes. Her chest hurt more than it ever had before, her breath catching every time Ava leaned closer to check their patient or the monitors. She knew this was bad, it shouldn’t get in the way of her work, but she couldn’t help it. By the time Sam walked into the room, asking her to move so he could check the patient’s cognitive function, her vision was getting fuzzy. Ava must have noticed because suddenly the other woman was taking her hand and dragging her into the hall, which had Sarah’s chest clenching horribly at the minor contact.
“Sarah,” she never used her first name and it made the resident want to cry, “Are you alright?”
She could only manage a small nod, eyes focused on the hand Ava still had in hers. The touch burned, making Sarah want to rip her hand away but not having the strength to even think about doing that.
“Your lips are blue,” Ava pointed out, “And your hands. I think we need to get you into a treatment room.”
“I’m f-fine,” she rasped, “I’ll be okay.”
“If you’re sick you shouldn’t be working; besides, you look like you’re about to pass out. Let me do a quick exam, please? Cyanosis with such a quick onset is a major cardio concern, Doctor Reese.”
That had Sarah yanking her hand from Ava’s grasp, ready to flee. There was no way she would let her do a cardiac workup on her, it would involve X-rays and scans so she would definitely notice her Hanahaki. Sarah didn’t want anyone knowing, but the thought of Ava in particular having any idea about it scared her more than surgery to remove the damn thing.
“I’m fine, Doctor Bekker,” she muttered, taking off down the hall before Ava could say another word. She rushed into the downstairs staff bathroom, sighing heavily when she realized it was thankfully empty. She felt déjà vu hit her hard as she stared at her reflection, the same place she always was during episodes at work, noting that Ava had been right about her being cyanotic. She was breathing harshly, gasping with every inhale because she couldn’t get enough oxygen otherwise. This was bad, she realized, as she felt like someone was squeezing her lungs so hard they would explode.
She didn’t even have time to grab onto the counter before she collapsed on the floor, her legs buckling without her consent. A sound of annoyance escaped Sarah, frustrated with how much pain she was in; all because of Ava. She didn’t blame her though, how could she? The other woman had no idea of her effect on Sarah, she just didn’t love her. It wasn’t her fault that she didn’t return Sarah’s feelings, it was Sarah’s own fault for being foolish enough to let it get this bad.
She couldn’t suppress the rough cough that shook her body, ripping angrily at her chest from the inside. It was a watery cough and Sarah knew her palm would be bloodied when she pulled it away from her mouth. She was suffocating from the inside and she didn’t know what to do, cursing quietly when she saw the handful of petals that had come up with her forceful coughing.
Maybe it would finally kill her, she mused bitterly to herself. Dying in the hospital bathroom was not her ideal way to go but at least she wouldn’t have to explain herself to anyone.
13 notes · View notes
rohans18 · 1 year ago
Text
Neuro-Behçet’s Disease Treatment Market Key Players, Outlook and Forecast 2028
Global Neuro-Behçet’s Disease Treatment Market, By Symptoms (Brainstem Syndrome, Multiple-Sclerosis like Presentations, Movement Disorders, Meningoencephalitic Syndrome, Myelopathic Syndrome, Cerebral Venous Sinus Thrombosis (CVST), and Intracranial Hypertension), Forms (Parenchymal and Non-Parenchymal), Treatment (Corticosteroids, Immunosuppressive Agents, Immunomodulators, Phosphodiesterase 4 (PDE4) Inhibitor, Interleukin-1β blocker and Others), Route Of Administration (Oral, Injectable), End Use (Hospitals, Homecare, Specialty Clinics, Others), Country (U.S., Canada, Mexico, Peru, Brazil, Argentina, Rest of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia Pacific, South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of the Middle East and Africa) Industry Trends and Forecast to 2028
The consistent Neuro-Behçet’s Disease Treatment market report analyzes many points that help businesses to solve the toughest questions in less time. The major topics of this business report are global growth trends, market share by manufacturers, market size by type, market size by application, production by region, consumption by region, company profiles, market forecast, value chain and sales channels analysis, opportunities & challenges, threat and affecting factors. The report gives market definition in the form of market driving factors and market restraints which helps estimating the demand of particular product depending on several aspects. Neuro-Behçet’s Disease Treatment market survey report studies the global market status and forecast, categorizes the global market size, market value & market volume by key players, type, application, and region.
Key Players
Some of the major players operating in the neuro-behçet’s disease market are Eisai Co., Ltd, AbbVie Inc, Amarillo Gear Company., XOMA, Mitsubishi Tanabe Pharma Corporation, CELGENE CORPORATION, Amneal Pharmaceuticals LLC, Annora Pharma Pvt, Novartis AG, Pfizer Inc., CELLTRION INC., F. Hoffmann-La Roche Ltd., Takeda Pharmaceutical Company Limited., Abbott, Les Laboratoires, Cell Medica Limited, Panacea Biotec Ltd., Coherus BioSciences, Servier, Lupin Pharmaceuticals Inc., among others.
 Browse More Info @ https://www.databridgemarketresearch.com/reports/global-neuro-behets-disease-treatment-market
One of the principal objectives of a high-ranking Neuro-Behçet’s Disease Treatment industry report is to analyze and study the global sales, value, status, and forecast. The market report also analyzes the global and key regions market potential and advantage, opportunity and challenge, restraints and risks. The report assists to define, describe and forecast the market by type, application and region. It estimates the region that is foretold to create the most number of opportunities in the global Neuro-Behçet’s Disease Treatment market. This market research report comprises of estimations of CAGR values which are quite significant and aids businesses to decide upon the investment value over the time period. An insightful Neuro-Behçet’s Disease Treatment market report assists clients to stay ahead of the time and competition.
Key questions answered in the report:
Which product segment will grab a lion’s share?
Which regional market will emerge as a frontrunner in coming years?
Which application segment will grow at a robust rate?
Report provides insights on the following pointers:
Market Penetration: Comprehensive information on the product portfolios of the top players in the Neuro-Behçet’s Disease Treatment Market.
Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and product launches in the market.
Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the market.
Table Of Content
Part 01: Executive Summary
Part 02: Scope Of The Report
Part 03:  Global Market
Part 04: Global Market Sizing
Part 05: Global Market Segmentation By Product
Part 06: Five Forces Analysis
 About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
0 notes